Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raloxifene”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Not applicableStudy completedNCT00031811
What this trial is testing

Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer

Who this might be right for
Breast CancerMenopausal SymptomsOsteoporosis
OHSU Knight Cancer Institute 80
Post-approval studies (Phase 4)Study completedNCT00361543
What this trial is testing

Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
The Alfred 54
Post-approval studies (Phase 4)Study completedNCT01041092
What this trial is testing

Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women

Who this might be right for
Schizophrenia
Fundació Sant Joan de Déu 34
Large-scale testing (Phase 3)Study completedNCT00389740
What this trial is testing

A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)

Who this might be right for
Osteoporosis, Postmenopausal
Organon and Co 400
Post-approval studies (Phase 4)Study completedNCT00079924
What this trial is testing

Effects of Teriparatide in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Eli Lilly and Company 200
Large-scale testing (Phase 3)Study completedNCT00481169
What this trial is testing

Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women

Who this might be right for
Osteoporosis
Wyeth is now a wholly owned subsidiary of Pfizer 1,742
Not applicableStudy completedNCT00774267
What this trial is testing

Study Evaluating Changes In Mammographic Breast Density

Who this might be right for
Osteoporosis
Pfizer 507
Post-approval studies (Phase 4)Active Not RecruitingNCT03623633
What this trial is testing

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosis
Massachusetts General Hospital 51
Very early researchStudy completedNCT01050842
What this trial is testing

Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+1 more
Mayo Clinic 18
Post-approval studies (Phase 4)Study completedNCT01544894
What this trial is testing

Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal OsteoporosisCompliance
University of Valencia 80
Large-scale testing (Phase 3)Study completedNCT05172050
What this trial is testing

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

Who this might be right for
SARS CoV 2 Infection
Dompé Farmaceutici S.p.A 61
Post-approval studies (Phase 4)Study completedNCT01481883
What this trial is testing

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
The Alfred 13
Not applicableStudy completedNCT00001837
What this trial is testing

Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients

Who this might be right for
Breast CancerBreast Neoplasm
National Institutes of Health Clinical Center (CC) 60
Not applicableUnknownNCT01973738
What this trial is testing

Comparison Between Raloxifene and Bazedoxifene

Who this might be right for
Selective Estrogen Receptor Modulator
Toshihiko Kono 300
Large-scale testing (Phase 3)Study completedNCT03043820
What this trial is testing

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
Iris Sommer 110
Not applicableStudy completedNCT00418236
What this trial is testing

Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density

Who this might be right for
Breast Cancer
Wyeth is now a wholly owned subsidiary of Pfizer 400
Not applicableStudy completedNCT02982083
What this trial is testing

Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sara Saeidi Shahri 34
Testing effectiveness (Phase 2)Study completedNCT00206557
What this trial is testing

The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
The Alfred 60
Large-scale testing (Phase 3)Study completedNCT01573637
What this trial is testing

Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women

Who this might be right for
Schizophrenia in Post Menopausal Women
Fundació Sant Joan de Déu 78
Post-approval studies (Phase 4)Study completedNCT00532246
What this trial is testing

Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

Who this might be right for
Osteoporosis, Post-Menopausal
Eli Lilly and Company 147
Next Page